Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Novartis AG
  6. Company
    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Novartis AG
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

Number of employees : 105 794 people.
Sales per Business
20192020Delta
Innovative Medicines37 479.5079.4%36 618.1080.2% -2.3%
Sandoz9 670.5020.5%9 053.8719.8% -6.38%
CHF in Million
Sales per region
2020
United States15 472.1033.9%
Europe10 282.5022.5%
Asia/Africa/Australasia4 544.7710%
Germany4 240.669.3%
Canada and Latin America3 042.056.7%
Japan2 631.875.8%
China2 415.055.3%
France2 292.105%
Switzerland750.891.6%
CHF in Million
Managers
Name Title Age Since
Vasant Narasimhan Chief Executive Officer 45 2018
Harry Werner Kirsch Chief Financial Officer 56 2013
John Tsai Chief Medical Officer 54 2018
Klaus Moosmayer Chief Ethics Risk & Compliance Officer 53 2018
Andreas von Planta, Dr. Independent Non-Executive Director 66 2006
Ann Marie Fudge Independent Non-Executive Director 70 2008
Enrico Cipro Vanni, Dr. Vice Chairman 70 2011
Charles L. Sawyers, Dr. Independent Non-Executive Director 62 2013
William Thomas Winters Independent Non-Executive Director 60 2013
J÷rg Reinhardt Independent Non-Executive Chairman 65 2013
Members of the board
Name Title Age Since
J÷rg Reinhardt Independent Non-Executive Chairman 65 2013
Andreas von Planta, Dr. Independent Non-Executive Director 66 2006
Ann Marie Fudge Independent Non-Executive Director 70 2008
Enrico Cipro Vanni, Dr. Vice Chairman 70 2011
Charles L. Sawyers, Dr. Independent Non-Executive Director 62 2013
William Thomas Winters Independent Non-Executive Director 60 2013
Nancy C. Andrews, Dr. Independent Non-Executive Director 62 2015
Mary Elizabeth Doherty Independent Non-Executive Director 64 2016
Ton BŘchner Independent Non-Executive Director 56 2016
Frans Van Houten Independent Non-Executive Director 61 2017
Shareholders
NameEquities%
Novartis AG 95,088,390 3.91%
Sandoz Family Foundation 89,135,960 3.66%
The Vanguard Group, Inc. 58,449,408 2.40%
UBS Asset Management Switzerland AG 56,764,402 2.33%
Norges Bank Investment Management 56,446,398 2.32%
Novartis Foundation For Employee Participation 49,094,512 2.02%
Wellington Management Co. LLP 43,097,437 1.77%
Credit Suisse Asset Management (Schweiz) AG 32,345,192 1.33%
ZŘrcher Kantonalbank (Investment Management) 22,916,663 0.94%
Dodge & Cox 22,514,870 0.92%
Holdings
NameEquities%Valuation
NOVARTIS INDIA LIMITED (500672) 17,450,680 70.7% 182,005,706 USD
SOMALOGIC, INC. (SLGC) 10,422,469 5.75% 121,317,539 USD
MOLECULAR PARTNERS AG (MOLN) 1,739,130 5.39% 33,916,600 USD
XOMA CORPORATION (XOMA) 539,131 4.77% 11,240,881 USD
GENSIGHT BIOLOGICS S.A. (SIGHT) 1,390,487 3.02% 8,791,813 USD
AYALA PHARMACEUTICALS, INC. (AYLA) 698,777 5.01% 5,946,592 USD
OXURION NV (OXUR) 2,177,226 5.57% 4,496,320 USD
TSCAN THERAPEUTICS, INC. (TCRX) 916,101 4.92% 4,122,455 USD
TSCAN THERAPEUTICS, INC. 863,045 8.63% 3,883,703 USD
BIOLINERX LTD. (BLRX) 4,999,995 0.70% 695,599 USD
Markets and indexes
- Primary listing
- SMI / FTSE Eurotop 100, Low Carbon 100 Europe, Stoxx Europe 50, STOXX Europe 600, Stoxx Global 200
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  NOVN.S
- Datastream Code :  S:NOVS
Company contact information
Novartis AG
Lichtstrasse 35
CH-4056 Basel, Basel-Stadt

Phone : +41 61 324 11 11
Fax : +41 61 324 80 01
web site : http://www.novartis.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Novartis AG
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
NOVARTIS AG-0.76%191 426
JOHNSON & JOHNSON-0.28%449 095
ROCHE HOLDING AG-6.46%307 637
PFIZER, INC.-9.62%299 559
ABBVIE INC.0.42%240 379
NOVO NORDISK A/S-12.29%219 960
ELI LILLY AND COMPANY-13.89%214 609
MERCK & CO., INC.5.14%203 541
ASTRAZENECA PLC1.82%183 389
BRISTOL-MYERS SQUIBB COMPANY-0.18%141 747
SANOFI7.12%132 839
AMGEN INC.-0.43%126 172
GLAXOSMITHKLINE PLC4.63%113 304
BAYER AG11.87%57 607
CHUGAI PHARMACEUTICAL CO., LTD-4.66%50 722
TAKEDA PHARMACEUTICAL COMPANY LIMITED4.78%44 351
JIANGSU HENGRUI MEDICINE CO., LTD.-19.25%41 130
DAIICHI SANKYO CO., LTD.-15.61%40 987
ASTELLAS PHARMA INC.-0.88%29 758
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY-18.94%19 813
YUNNAN BAIYAO GROUP CO.,LTD-13.73%18 284